期刊文献+

神经生长颗粒对大鼠坐骨神经挤压伤修复的影响 被引量:1

Effects of Nerve Growth Granules on Recovery of Scatic Nerve Crush Injury
下载PDF
导出
摘要 目的:研究神经生长颗粒对大鼠坐骨神经挤压伤修复的影响。方法:雌性SD大鼠60只,麻醉后行坐骨神经夹伤术。术后第2天开始灌药,并随机分为5组:阳性对照弥可保组;实验组神经生长颗粒高、中、低剂量组;生理盐水阴性对照组。灌药后3周,通过对术后动物的整体观察,压伤段神经电生理学检测和腓肠肌组织学形态测量,评价修复效果。结果:灌药后3周,大鼠坐骨神经干复合肌动作电位(CMAP)和神经传导速度(MCV),NGG高剂量组与弥可保组比较差异无统计学意义,明显优于生理盐水组;腓肠肌肌湿重比,NGG高、中剂量组与弥可保组比较差异无统计学意义,均显著优于生理盐水组;胶原纤维面积NGG高剂量组与弥可保组比较差异无统计学意义,显著低于生理盐水组。结论:神经生长颗粒有明显的促神经再生和促神经功能恢复的作用。 Objective: To evaluate the effects of nerve growth granules on rat sciatic nerve crush injury recovery.Methods: Sixty female SD rats were randomly divided into five groups: The methycobal group as the positive control,three NGG groups(high,moderate and low dose),and saline as the negative control.Electrophysiology and histochemistry were performed after 3 weeks of sciatic nerve crush operation.Results: The CMAP amplitude ratio and the MCV value showed no significant difference between the NGG high dose group and Methycobal group;in addition,CAMP and the MCV value amplitude ratio were significantly larger in either the NGG high dose group or the Methycobal group than in the saline group.Gastrocnemius muscle wet weight ratio and Masson trichrome indicated that the astrocnemius muscle atrophy was less serious in the NGG high dose group and the Methycobal group than in the saline group.Conclusions: NGG could promote peripheral nerve regeneration and recovery of its function.
出处 《交通医学》 2012年第1期1-3,9,共4页 Medical Journal of Communications
基金 国家自然科学基金资助项目(81000678)
关键词 坐骨神经挤压伤 神经生长颗粒 周围神经再生 大鼠 sciatic nerve crush injury nerve growth granule peripheral nerve regeneration Rats
  • 相关文献

参考文献12

二级参考文献118

共引文献72

同被引文献17

  • 1张琦,汤欣,丁斐.神经再生素促大鼠背根神经节生长作用的研究[J].解剖学报,2006,37(1):36-39. 被引量:6
  • 2Andeerson KC, Alsina M, Bensinger W, et al. NCCN clinical practice guidelines in oncology: multiple myeloma[J]. Versionl, 2009,7 (9) :908-942.
  • 3Richardson PG, Delforge M, Beksac M, et al. Management of treatment-emergent peripheral neuropathy in multiple myeloma[J]. Leukemia, 2012, 26(4): 595-608.
  • 4Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature [ J ]. Blood, 2008, 112 (5): 593-599.
  • 5Richardson PG, Sonneveld P, Schuster MW, et al. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline EJ]. Br J Hematol, 2009, 144 (6): 895-903.
  • 6Cavaletti G, Gilardini A, Canta A, et al. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat[J]. Exp Neurol, 2007, 204( 1 ): 317-325.
  • 7Poruchynsky MS, Sackett DL, Robey RW, et al. Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition[ J ]. Cell Cycle, 2008, 7 (7) : 940-949.
  • 8Julien JP, Mushynski WE. Neurofilaments in health and disease IJ]. Prog Nucleic Acid Res Mol Biol, 1998, 61 : 1-23.
  • 9Festof BW, Nelson PG, Brenneman DE. Prevention of activity- dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin- inhibiting neurotrophic serpin, protease nexin I [J]. J Neurobiol, 1996, 30 (2): 255-266.
  • 10Brenneman DE, Hill JM, Glazner GW, et al. Interleukin- 1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival [ J ]. Int J Dev Neurosci, 1995, 13 (3- 4): 187-.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部